James Hodovan

Echo Technologist
Oregon Health & Science University

Presentation(s):

• OC 58.4 - Ibrutinib inhibits BMX-dependent endothelial VCAM-1 expression in vitro and pro-atherosclerotic endothelial activation and platelet adhesion in vivo

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM